Literature DB >> 29427869

Performance of four diagnostic approaches to depression in adults with cancer.

Rebecca M Saracino1, Barry Rosenfeld2, Christian J Nelson3.   

Abstract

OBJECTIVE: The potentially confounding influence of somatic symptoms in identifying depression in medically ill patients has long been of concern, resulting in several proposed alternative diagnostic approaches. These approaches have been compared in the cancer setting, but the strengths and weaknesses of the alternative approaches have rarely been examined. The purpose of the current study was to examine the performance of four approaches to depression assessment among ambulatory cancer patients.
METHOD: Outpatients were recruited from a large cancer center (N = 611). Participants had to be 40 years or older, English-speaking, and have a cancer diagnosis. All participants completed a sociodemographic questionnaire and a modified Patient Health Questionnaire-9 with additional items targeting the Endicott and Cavanaugh substitutive criteria.
RESULTS: Depression prevalence varied significantly by diagnostic approach, with the inclusive approach identifying the largest proportion as depressed (9.3%, n = 57), followed by the Endicott-substitutive (6.2%, n = 38), exclusive (4.6%, n = 28), and Cavanaugh-substitutive approach (1.8%, n = 11). Somatic items were significantly elevated across all four approaches.
CONCLUSIONS: The inclusive approach that retains use of somatic symptoms is appropriate when screening cancer patients for depression. The fact that somatic symptoms were more prevalent across approaches suggests that they may not inflate the prevalence of depression as much as some have feared. Rather, somatic items may explain variance in depressive symptoms beyond that explained by the presence of cancer and its treatment. Additionally, the Endicott items appeared useful for capturing depressive symptoms that are not included in the existing DSM criteria, and may have a place in clinical and research settings.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assessment/diagnosis; Cancer; Depression; Measurement/psychometrics

Mesh:

Year:  2018        PMID: 29427869      PMCID: PMC5869111          DOI: 10.1016/j.genhosppsych.2018.01.006

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  34 in total

1.  Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer.

Authors:  Lesley Stafford; Fiona Judd; Penny Gibson; Angela Komiti; Michael Quinn; G Bruce Mann
Journal:  Gen Hosp Psychiatry       Date:  2013-11-05       Impact factor: 3.238

2.  Medical co-morbidity and validity of DSM-IV depression criteria.

Authors:  Gregory E Simon; Michael Von Korff
Journal:  Psychol Med       Date:  2005-10-05       Impact factor: 7.723

Review 3.  Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force.

Authors:  William F Pirl; Jesse R Fann; Joseph A Greer; Ilana Braun; Teresa Deshields; Caryl Fulcher; Elizabeth Harvey; Jimmie Holland; Vicki Kennedy; Mark Lazenby; Lynne Wagner; Meghan Underhill; Deborah K Walker; James Zabora; Bradley Zebrack; Wayne A Bardwell
Journal:  Cancer       Date:  2014-05-02       Impact factor: 6.860

4.  Psychosocial distress screening implementation in cancer care: an analysis of adherence, responsiveness, and acceptability.

Authors:  Brad Zebrack; Karen Kayser; Laura Sundstrom; Sue Ann Savas; Chris Henrickson; Chiara Acquati; Rebecca L Tamas
Journal:  J Clin Oncol       Date:  2015-02-23       Impact factor: 44.544

5.  Measurement of depression in patients with cancer.

Authors:  J Endicott
Journal:  Cancer       Date:  1984-05-15       Impact factor: 6.860

6.  Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients.

Authors:  Masatoshi Inagaki; Tatsuo Akechi; Toru Okuyama; Yuriko Sugawara; Hiroya Kinoshita; Yasuo Shima; Kimio Terao; Shuichi Mitsunaga; Atsushi Ochiai; Yosuke Uchitomi
Journal:  Support Care Cancer       Date:  2013-02-28       Impact factor: 3.603

7.  Screening for depression in head and neck cancer.

Authors:  Mark R Katz; Neil Kopek; John Waldron; Gerald M Devins; George Tomlinson
Journal:  Psychooncology       Date:  2004-04       Impact factor: 3.894

8.  Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria.

Authors:  Tatsuo Akechi; Tetsuji Ietsugu; Masune Sukigara; Hitoshi Okamura; Tomohito Nakano; Nobuya Akizuki; Masako Okamura; Ken Shimizu; Toru Okuyama; Toshiaki A Furukawa; Yosuke Uchitomi
Journal:  Gen Hosp Psychiatry       Date:  2009-02-01       Impact factor: 3.238

9.  The clinical epidemiology of depression in palliative care and the predictive value of somatic symptoms: cross-sectional survey with four-week follow-up.

Authors:  Lauren Rayner; William Lee; Annabel Price; Barbara Monroe; Nigel Sykes; Penny Hansford; Irene J Higginson; Matthew Hotopf
Journal:  Palliat Med       Date:  2011-01-12       Impact factor: 4.762

10.  The association of depression and anxiety with pain: a study from NESDA.

Authors:  Eric W de Heer; Marloes M J G Gerrits; Aartjan T F Beekman; Jack Dekker; Harm W J van Marwijk; Margot W M de Waal; Philip Spinhoven; Brenda W J H Penninx; Christina M van der Feltz-Cornelis
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

View more
  4 in total

1.  Latent Profile Analyses of Depressive Symptoms in Younger and Older Oncology Patients.

Authors:  Rebecca M Saracino; Heining Cham; Barry Rosenfeld; Christian J Nelson
Journal:  Assessment       Date:  2018-06-27

2.  The Sickness Behavior Inventory-Revised: Sickness behavior and its associations with depression and inflammation in patients with metastatic lung cancer.

Authors:  Daniel C McFarland; Leah E Walsh; Rebecca Saracino; Christian J Nelson; William Breitbart; Barry Rosenfeld
Journal:  Palliat Support Care       Date:  2021-06

3.  Are we accurately evaluating depression in patients with cancer?

Authors:  Rebecca M Saracino; Ezgi Aytürk; Heining Cham; Barry Rosenfeld; Leah M Feuerstahler; Christian J Nelson
Journal:  Psychol Assess       Date:  2019-08-08

4.  Evaluating relationships between lung cancer stigma, anxiety, and depressive symptoms and the absence of empathic opportunities presented during routine clinical consultations.

Authors:  Timothy J Williamson; Jamie S Ostroff; Chloé M Martin; Smita C Banerjee; Carma L Bylund; Heidi A Hamann; Megan Johnson Shen
Journal:  Patient Educ Couns       Date:  2020-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.